2013
DOI: 10.1111/ijcp.12128
|View full text |Cite
|
Sign up to set email alerts
|

The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study

Abstract: The low FODMAP diet shows efficacy for IBS patients. The current strategy of breath testing and dietary advice provides a good basis to understand and adhere to the diet.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
223
1
14

Year Published

2015
2015
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 261 publications
(254 citation statements)
references
References 31 publications
12
223
1
14
Order By: Relevance
“…10,29,30 This rapid improvement is likely to be the result of osmotic and motility changes in the gut. 9 The durability of such benefits have been suggested in a prospective observational study, 31 but further study of longer term effects are warranted. Adverse effects of the low FODMAP diet in the short-term have not been identified.…”
Section: Efficacy Of the Low Fodmap Dietmentioning
confidence: 99%
“…10,29,30 This rapid improvement is likely to be the result of osmotic and motility changes in the gut. 9 The durability of such benefits have been suggested in a prospective observational study, 31 but further study of longer term effects are warranted. Adverse effects of the low FODMAP diet in the short-term have not been identified.…”
Section: Efficacy Of the Low Fodmap Dietmentioning
confidence: 99%
“…Improvement in bloating was reported by Staudacher et al, (30) who evaluated written information on LFDs versus 'standard' diets (82% vs. 49%; p = 0.002). In de Roest et al's (31) study, 18.2% of the subjects felt that a food list was as effective as a dietitian consult. Web-based self-management programmes have also proven to be feasible approaches to chronic diseases.…”
Section: Discussionmentioning
confidence: 95%
“…Data from these studies were reviewed. Seven out of the 17 studies evaluated bloating as a secondary outcome, (6,22,(27)(28)(29)(30)(31) while the majority evaluated bloating as a composite endpoint. The IBS symptom severity score (SSS) was used in five (23,24,(32)(33)(34) of the ten studies that evaluated bloating as part of a composite endpoint, while the other ten studies used a varying visual analogue scale (VAS) or Likert scale.…”
Section: Papers Selectedmentioning
confidence: 99%
See 1 more Smart Citation
“…A leggyakoribb a komplex-IV-hiány, de a súlyos tünetekkel járó öröklődő betegség hátterében a koenzim Q csökkent mennyiségét is igazolták. Koenzim Q pótlása mérsékli a tüneteket [13].…”
Section: Az áJurvéda Tudománya éS Elfogadottságaunclassified